Ther Clin Risk Manag. 2017 Oct 24;13:1463-1478. doi: 10.2147/TCRM.S144418. eCollection 2017.
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review.
Therapeutics and clinical risk management
Maurizio Sessa, Claudia Rossi, Annamaria Mascolo, Cristina Scavone, Gabriella di Mauro, Roberto Grassi, Liberata Sportiello, Salvatore Cappabianca, Concetta Rafaniello
Affiliations
Affiliations
- Section of Pharmacology "L Donatelli", Department of Experimental Medicine, University of Campania "L Vanvitelli", Naples, Italy.
- Section of Radiology and Radiotherapy, Department of Clinical and Experimental Medicine "Magrassi-Lanzara", University of Campania "L Vanvitelli", Naples, Italy.
PMID: 29123405
PMCID: PMC5661489 DOI: 10.2147/TCRM.S144418
Abstract
BACKGROUND AND OBJECTIVE: The use of contrast media in Italy has exponentially increased in the past 3 decades. However, it is unknown whether there has been an increase in clinical research evaluating the risks associated with contrast media usage, especially regarding contrast-induced nephropathy. To fill this gap in knowledge, we performed a systematic review.
STUDY ELIGIBILITY CRITERIA: Meta-analyses, observational studies, and clinical trials assessing contrast media-induced nephropathy as the safety outcome, in which at least one author was affiliated with an Italian university/health care structure, were eligble.
DATA SOURCES: Ovid MEDLINE, Ovid Embase, Cochrane Methodology Register, and Web of Science were screened.
PARTICIPANTS: Men and women exposed to contrast media.
RESULTS: In total, 60 original articles were retrieved with an incremental trend between 1990 and 2017. Cohort studies were the most common study design represented. In total, 45 of 60 (75.0%) studies were monocenter studies and 41 of 60 (68.3%) received no funding. In all, 91.7% of studies disclosed no conflicts of interest and 81.7% had no external collaboration. Most of the studies provided a level of evidence of III-2 (32/60; 53.3%) and II (23/60; 38.3%). In total, 50 of 60 studies (83.3%) were published in a scientific journal ranked in the first quartile of their subject area.
CONCLUSION: There was an increased number of studies evaluating contrast-induced nephropathy in Italy during the last three decades. These studies covered procedures to prevent contrast-induced nephropathy or aimed to identify risk factors, biomarkers, and scores, and their related prognosis.
Keywords: Italy; adverse drug reaction; contrast media; drug safety; nephropathy; pharmacovigilance; post-marketing surveillance; systematic review
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
- Am J Cardiol. 2008 Apr 15;101(8):1112-8 - PubMed
- Circulation. 2012 Dec 18;126(25):3008-16 - PubMed
- Ann Intern Med. 2009 Feb 3;150(3):170-7 - PubMed
- Int J Cardiol. 2015 Mar 15;183:47-53 - PubMed
- Am J Cardiol. 2006 Sep 18;98(6A):59K-77K - PubMed
- Invest Radiol. 1994 Apr;29(4):480-4 - PubMed
- J Cardiovasc Magn Reson. 2015 Jul 14;17:58 - PubMed
- Eur J Radiol. 1994 May;18 Suppl 1:S73-6 - PubMed
- Am J Med. 2006 Feb;119(2):155-62 - PubMed
- Eur Heart J. 2014 Jun 14;35(23):1533-40 - PubMed
- PLoS One. 2016 Jul 28;11(7):e0160337 - PubMed
- Circ Cardiovasc Interv. 2014 Aug;7(4):465-72 - PubMed
- J Nephrol. 2012 Nov-Dec;25(6):1098-107 - PubMed
- Am J Cardiol. 2011 Jul 1;108(1):1-7 - PubMed
- Circulation. 2007 Mar 13;115(10 ):1211-7 - PubMed
- Am J Med. 2010 Aug;123(8):755-63 - PubMed
- Scand J Urol Nephrol. 2000 Oct;34(5):317-22 - PubMed
- Circulation. 2012 Jun 26;125(25):3099-107 - PubMed
- Expert Opin Drug Saf. 2016 Dec;15(sup2):51-59 - PubMed
- In Vivo. 2008 Jan-Feb;22(1):123-9 - PubMed
- N Engl J Med. 2003 Oct 2;349(14):1333-40 - PubMed
- Curr Probl Diagn Radiol. 2006 Jul-Aug;35(4):164-9 - PubMed
- Eur Radiol. 2011 Jan;21(1):63-9 - PubMed
- Circulation. 2010 May 18;121(19):2117-22 - PubMed
- Am J Cardiol. 2012 Jan 1;109 (1):67-74 - PubMed
- G Ital Nefrol. 2002 Sep-Oct;19(5):529-33 - PubMed
- BMC Med Res Methodol. 2009 Jun 11;9:34 - PubMed
- Int J Cardiol. 2017 Jan 15;227:734-742 - PubMed
- Am Heart J. 2011 May;161(5):963-71 - PubMed
- Am Heart J. 2010 Dec;160(6):1170-7 - PubMed
- J Am Soc Nephrol. 1995 Nov;6(5):1451-8 - PubMed
- Artif Organs. 2010 Jun;34(6):E193-9 - PubMed
- N Engl J Med. 2006 Jun 29;354(26):2773-82 - PubMed
- Am J Cardiol. 2014 Aug 15;114(4):541-8 - PubMed
- Circ Cardiovasc Interv. 2011 Oct 1;4(5):456-62 - PubMed
- Insights Imaging. 2013 Dec;4(6):811-20 - PubMed
- Intern Emerg Med. 2011 Dec;6(6):503-7 - PubMed
- Circulation. 2011 Sep 13;124(11):1260-9 - PubMed
- Acta Radiol. 2008 Jul;49(6):646-57 - PubMed
- Minerva Anestesiol. 2004 Apr;70(4):189-91 - PubMed
- Acta Radiol. 2010 May;51(4):462-6 - PubMed
- JACC Cardiovasc Interv. 2012 Jan;5(1):90-7 - PubMed
- J Am Coll Cardiol. 2014 Jan 7-14;63(1):71-9 - PubMed
- Catheter Cardiovasc Interv. 2015 Jul;86(1):E19-27 - PubMed
- AJR Am J Roentgenol. 2015 Jun;204(6):1174-81 - PubMed
- Expert Opin Drug Saf. 2016 Dec;15(sup2):9-15 - PubMed
- J Am Coll Cardiol. 2004 Aug 18;44(4):762-5 - PubMed
- Circ Cardiovasc Interv. 2015 Sep;8(9):e002673 - PubMed
- Clin Chem. 2012 Feb;58(2):458-64 - PubMed
- Catheter Cardiovasc Interv. 2015 Nov;86(5):950-7 - PubMed
- Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:13-21 - PubMed
- Drug Saf. 2016 May;39(5):401-7 - PubMed
- J Cardiovasc Pharmacol Ther. 2016 Mar;21(2):159-66 - PubMed
- J Pharmacol Pharmacother. 2016 Apr-Jun;7(2):106-8 - PubMed
- J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5 - PubMed
- Chem Immunol Allergy. 2012;97:180-90 - PubMed
- Angiology. 2015 Apr;66(4):333-8 - PubMed
- Pharmacol Res. 2016 Feb;104:108-14 - PubMed
- Chem Rev. 2013 Mar 13;113(3):1641-66 - PubMed
- Cardiovasc Hematol Agents Med Chem. 2009 Apr;7(2):166-80 - PubMed
- Nephron. 1990;55(3):254-7 - PubMed
- Invest Radiol. 2001 Jun;36(6):309-16 - PubMed
- Med Arh. 1999;53(3 Suppl 3):57-60 - PubMed
- Radiol Med. 2001 Mar;101(3):109-10 - PubMed
- Anesth Analg. 2013 Aug;117(2):455-61 - PubMed
- Ann Thorac Surg. 2013 Feb;95(2):513-9 - PubMed
- J Am Coll Surg. 2008 Feb;206(2):361-9 - PubMed
- Expert Opin Drug Saf. 2015;14(9):1341-51 - PubMed
- Am J Cardiol. 2010 Feb 1;105(3):288-92 - PubMed
- Expert Opin Drug Saf. 2014 Sep;13 Suppl 1:S21-9 - PubMed
- Int J Cardiol. 2016 May 1;210:4-9 - PubMed
- Eur Heart J. 2004 Feb;25(3):206-11 - PubMed
- Expert Opin Drug Saf. 2016 Dec;15(sup2):85-100 - PubMed
- Catheter Cardiovasc Interv. 2003 Jan;58(1):59-64 - PubMed
- J Cardiovasc Med (Hagerstown). 2014 Jul;15(7):587-94 - PubMed
- Biochem Med (Zagreb). 2014;24(2):199-210 - PubMed
- J Am Coll Cardiol. 2002 Jul 17;40(2):298-303 - PubMed
- Am J Cardiol. 2014 Feb 15;113(4):588-92 - PubMed
- Int J Cardiol. 2014 Mar 15;172(2):375-80 - PubMed
- Eur Radiol. 1998;8(1):144-7 - PubMed
- J Cardiovasc Med (Hagerstown). 2006 Oct;7(10 ):737-41 - PubMed
- JACC Cardiovasc Interv. 2015 Sep;8(11):1506-14 - PubMed
- J Thromb Thrombolysis. 2014 Nov;38(4):493-502 - PubMed
- J Cardiovasc Med (Hagerstown). 2010 Jun;11(6):444-9 - PubMed
- Am Heart J. 2016 Mar;173:67-76 - PubMed
- N Engl J Med. 2000 Jul 20;343(3):210-2 - PubMed
- JACC Cardiovasc Interv. 2014 Dec;7(12 ):1421-9 - PubMed
- Kidney Int. 2005 Nov;68(5):2250-5 - PubMed
- Int J Cardiol. 2014 Jun 1;174(1):37-42 - PubMed
Publication Types